(Q79765072)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Galland F

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Duvillard L

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Petit JM

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Lagrost L

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Vaillant G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Brun JM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Gambert P

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Vergès B

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

published in

Diabetes and Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

625-631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Modification of lipoproteins in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Greater effect of diabetes on LDL size in women than in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glucosylation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Lipoprotein glycation and its metabolic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Lipid peroxidation and atherosclerosis in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Improvement of the plasma lipoprotein pattern after institution of insulin treatment in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Small, dense low-density lipoprotein as a risk factor for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Intensive Insulin Therapy Exerts Antiinflammatory Effects in Critically Ill Patients and Counteracts the Adverse Effect of Low Mannose-Binding Lectin Levels

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

Is insulin an antiinflammatory molecule?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970318-X

7 January 2021

10.1016/S1262-3636(07)70318-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17296517%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference